Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole
The etiology of Crohn's disease (CD) remains controversial. It is hypothesized that CD is the result of an abnormal immune response to the gut flora in genetically susceptible hosts. However, an infectious etiology has not been completely ruled out. Antibiotics have been utilized with some succ...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-01-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/369965 |
id |
doaj-8dff0ffafc304dd9889f0debbcb3a90c |
---|---|
record_format |
Article |
spelling |
doaj-8dff0ffafc304dd9889f0debbcb3a90c2020-11-24T23:03:45ZengKarger PublishersCase Reports in Gastroenterology1662-06312015-01-0191252810.1159/000369965369965Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and MetronidazoleNeil D. GoldbergAravinda VadlamudiNicole ParrishThe etiology of Crohn's disease (CD) remains controversial. It is hypothesized that CD is the result of an abnormal immune response to the gut flora in genetically susceptible hosts. However, an infectious etiology has not been completely ruled out. Antibiotics have been utilized with some success to modify the course of the disease. Here, we report a patient with CD and pyoderma gangrenosum refractory to standard therapy, including biologics, who achieved remission with a combination of rifaximin, gentamicin and metronidazole.http://www.karger.com/Article/FullText/369965Combination therapyCrohnߣs diseasePyoderma gangrenosum |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Neil D. Goldberg Aravinda Vadlamudi Nicole Parrish |
spellingShingle |
Neil D. Goldberg Aravinda Vadlamudi Nicole Parrish Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole Case Reports in Gastroenterology Combination therapy Crohnߣs disease Pyoderma gangrenosum |
author_facet |
Neil D. Goldberg Aravinda Vadlamudi Nicole Parrish |
author_sort |
Neil D. Goldberg |
title |
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole |
title_short |
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole |
title_full |
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole |
title_fullStr |
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole |
title_full_unstemmed |
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and Metronidazole |
title_sort |
treatment of refractory crohn's disease and pyoderma gangrenosum with a combination regimen of rifaximin, gentamicin and metronidazole |
publisher |
Karger Publishers |
series |
Case Reports in Gastroenterology |
issn |
1662-0631 |
publishDate |
2015-01-01 |
description |
The etiology of Crohn's disease (CD) remains controversial. It is hypothesized that CD is the result of an abnormal immune response to the gut flora in genetically susceptible hosts. However, an infectious etiology has not been completely ruled out. Antibiotics have been utilized with some success to modify the course of the disease. Here, we report a patient with CD and pyoderma gangrenosum refractory to standard therapy, including biologics, who achieved remission with a combination of rifaximin, gentamicin and metronidazole. |
topic |
Combination therapy Crohnߣs disease Pyoderma gangrenosum |
url |
http://www.karger.com/Article/FullText/369965 |
work_keys_str_mv |
AT neildgoldberg treatmentofrefractorycrohnsdiseaseandpyodermagangrenosumwithacombinationregimenofrifaximingentamicinandmetronidazole AT aravindavadlamudi treatmentofrefractorycrohnsdiseaseandpyodermagangrenosumwithacombinationregimenofrifaximingentamicinandmetronidazole AT nicoleparrish treatmentofrefractorycrohnsdiseaseandpyodermagangrenosumwithacombinationregimenofrifaximingentamicinandmetronidazole |
_version_ |
1725632361031270400 |